GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Cash Flow for Dividends

G.Barekat Pharm (XTEH:BRKT1) Cash Flow for Dividends : IRR0 Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Cash Flow for Dividends?

G.Barekat Pharm's cash flow for dividends for the six months ended in Mar. 2017 was IRR0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

G.Barekat Pharm Cash Flow for Dividends Historical Data

The historical data trend for G.Barekat Pharm's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Cash Flow for Dividends Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Cash Flow for Dividends
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Cash Flow for Dividends - -

G.Barekat Pharm Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G.Barekat Pharm Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Cash Flow for Dividends
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines